REVIEW |
Addressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop Proceedings
Affiliations of authors: Department of Nutrition, School of Public Health, Loma Linda University, Loma Linda, CA, and Nutrition Matters, Inc, Port Townsend, WA (MM); Division of Cancer Prevention, National Cancer Institute, Bethesda, MD (WMS); Fred Hutchinson Cancer Research Center, Seattle, WA (JWL).
Correspondence to: Mark Messina, PhD, Nutrition Matters, Inc., 439 Calhoun St., Port Townsend, WA 98368 (e-mail: markm{at}olympus.net).
The impact of soyfood intake on breast cancer risk has been investigated extensively. Much of this focus can be attributed to the soybean being a dietary source that is uniquely rich in isoflavones. The chemical structure of isoflavones is similar to that of estrogen, and isoflavones bind to both estrogen receptors (ER
and ER
) (although they preferentially bind to and activate ER) and exert estrogen-like effects under some experimental conditions. Isoflavones also possess nonhormonal properties that are associated with the inhibition of cancer cell growth. Thus, there are several possible mechanisms by which soy may reduce the risk of breast cancer. However, the role of isoflavones in breast cancer has become controversial because, in contrast to the possible beneficial effects, some data from in vitro and animal studies suggest that isoflavones, especially genistein, the aglycone of the main soybean isoflavone genistin, may stimulate the growth of estrogen-sensitive tumors. Limited human data directly address the tumor-promoting effects of isoflavones and soy. Because the use of soyfoods and isoflavone supplements is increasing, it is important from a public health perspective to understand the impact of these products on breast cancer risk in women at high risk of the disease and on the survival of breast cancer patients. To this end, a workshop was held in November 2005 to review the existing literature and to make research recommendations. This paper summarizes the workshop findings and recommendations. The primary research recommendation is that the impact of isoflavones on breast tissue needs to be evaluated at the cellular level in women at high risk for breast cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Hooper, J.J. Ryder, M.S. Kurzer, J.W. Lampe, M.J. Messina, W.R. Phipps, and A. Cassidy Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis Hum. Reprod. Update, July 1, 2009; 15(4): 423 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Lee, X.-O. Shu, H. Li, G. Yang, H. Cai, W. Wen, B.-T. Ji, J. Gao, Y.-T. Gao, and W. Zheng Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Chang, J.-H. Chiu, C.-W. Wu, and W.-Y. Lui Herb-related aneuploidy in breast fibroadenoma BMJ Case Reports, May 12, 2009; 2009(may12_1): bcr0920080926 - bcr0920080926. [Abstract] [Full Text]
|
|
|
|
|
|
M. Messina and A. H Wu Perspectives on the soy-breast cancer relation Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1673S - 1679S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Badger, J. M Gilchrist, R T. Pivik, A. Andres, K. Shankar, J.-R. Chen, and M. J Ronis The health implications of soy infant formula Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1668S - 1672S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maskarinec, M. Verheus, F. M. Steinberg, P. Amato, M. K. Cramer, R. D. Lewis, M. J. Murray, R. L. Young, and W. W. Wong Various Doses of Soy Isoflavones Do Not Modify Mammographic Density in Postmenopausal Women J. Nutr., May 1, 2009; 139(5): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Korde, A. H. Wu, T. Fears, A. M.Y. Nomura, D. W. West, L. N. Kolonel, M. C. Pike, R. N. Hoover, and R. G. Ziegler Childhood Soy Intake and Breast Cancer Risk in Asian American Women Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1050 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Messina, S. Watanabe, and K. D. R. Setchell Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment J. Nutr., April 1, 2009; 139(4): 796S - 802S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Raju, A. Bielecki, D. Caldwell, E. Lok, M. Taylor, K. Kapal, I. Curran, G. M. Cooke, R. P. Bird, and R. Mehta Soy Isoflavones Modulate Azoxymethane-Induced Rat Colon Carcinogenesis Exposed Pre- and Postnatally and Inhibit Growth of DLD-1 Human Colon Adenocarcinoma Cells by Increasing the Expression of Estrogen Receptor-{beta} J. Nutr., March 1, 2009; 139(3): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Verheus, C. H. van Gils, S. Kreijkamp-Kaspers, L. Kok, P. H.M. Peeters, D. E. Grobbee, and Y. T. van der Schouw Soy Protein Containing Isoflavones and Mammographic Density in a Randomized Controlled Trial in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2632 - 2638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Orgaard and L. Jensen The Effects of Soy Isoflavones on Obesity Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dip, S. Lenz, J.-P. Antignac, B. Le Bizec, H. Gmuender, and H. Naegeli Global gene expression profiles induced by phytoestrogens in human breast cancer cells Endocr. Relat. Cancer, March 1, 2008; 15(1): 161 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lehmann, L. Jiang, and J. Wagner Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells Carcinogenesis, February 1, 2008; 29(2): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Fuhrman, B. E. Teter, M. Barba, C. Byrne, A. Cavalleri, B. J. Grant, P. J. Horvath, D. Morelli, E. Venturelli, and P. C. Muti Equol Status Modifies the Association of Soy Intake and Mammographic Density in a Sample of Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, M. C. Pike, L. D. Williams, D. Spicer, C.-C. Tseng, M. I. Churchwell, and D. R. Doerge Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer J. Clin. Oncol., July 20, 2007; 25(21): 3024 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gallo, E. Mantuano, M. Fabrizi, C. Ferlini, S. Mozzetti, I. De Stefano, and G. Scambia Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 317 - 324. [Abstract] [Full Text] [PDF]
|
|